Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Fatty Liver × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 119 Breast Neoplasms 34 Prostatic Neoplasms 29 Insulin Resistance 27 Obesity 18 Endometrial Neoplasms 13 Pancreatic Neoplasms 12 Neoplasms 12 Infertility 12 Colorectal Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Anovulation 10 Lung Neoplasms 8 Neoplasm Metastasis 7 Metabolic Syndrome 7 Hyperandrogenism 7 Glioblastoma 7 Squamous Cell Carcinoma of Head and Neck 6 Melanoma 6 Lymphoma, Large B-Cell, Diffuse 5 Diabetes Mellitus 5 Adenocarcinoma 5 Weight Loss 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Mouth Neoplasms 4 Head and Neck Neoplasms 4 Brain Neoplasms 4 Adenocarcinoma of Lung 4 Urinary Bladder Neoplasms 3

Interventions

penclomedine 1 atezolizumab 1 Triptorelin Pamoate 1 Orchiectomy 1 Olive Oil 1 Metformin 1 Exenatide 1 Excitatory Amino Acids 1 Diet, Ketogenic 1 Bevacizumab 1 Amino Acids, Essential 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01523639 2018-12-19

G-LUCAS

Austrian Breast & Colorectal Cancer Study Group

Phase 2 Terminated

Gastrointestinal

Fatty Liver, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡